博拓生物
(688767)
| 流通市值：61.14亿 | | | 总市值：61.14亿 |
| 流通股本：1.49亿 | | | 总股本：1.49亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 214,684,129.57 | 89,376,734.08 | 448,012,337.89 | 308,071,086.61 |
| 营业总成本 | 236,469,943.71 | 103,998,265.43 | 415,659,935.1 | 290,697,562.31 |
| 其他经营收益 | | | | |
| 营业利润 | -24,089,731.28 | -14,642,878.23 | 50,524,884.9 | 22,696,605.66 |
| 利润总额 | -23,622,640.42 | -14,423,839.83 | 49,681,667.11 | 22,731,952.38 |
| 净利润 | -17,094,519.68 | -10,532,237.7 | 47,126,834.92 | 20,387,628.12 |
| 每股收益 | | | | |
| 其他综合收益 | 754,523.45 | 302,036.41 | 297,744.75 | 1,082,332.56 |
| 综合收益总额 | -16,339,996.23 | -10,230,201.29 | 47,424,579.67 | 21,469,960.68 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,446,061,760.02 | 1,580,331,727.86 | 1,661,485,204.52 | 1,703,141,102.85 |
| 非流动资产: | | | | |
| 非流动资产合计 | 959,415,475.72 | 905,665,233.93 | 877,938,816.49 | 771,871,643.45 |
| 资产总计 | 2,405,477,235.74 | 2,485,996,961.79 | 2,539,424,021.01 | 2,475,012,746.3 |
| 流动负债: | | | | |
| 流动负债合计 | 152,109,713.91 | 111,982,115.01 | 157,976,497.22 | 124,703,448.63 |
| 非流动负债: | | | | |
| 非流动负债合计 | 108,831,776.18 | 9,751,160.28 | 10,191,636.08 | 10,050,205.26 |
| 负债合计 | 260,941,490.09 | 121,733,275.29 | 168,168,133.3 | 134,753,653.89 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,140,968,969.16 | 2,360,480,529.97 | 2,369,789,814.77 | 2,338,542,228.33 |
| 股东权益合计 | 2,144,535,745.65 | 2,364,263,686.5 | 2,371,255,887.71 | 2,340,259,092.41 |
| 负债和股东权益合计 | 2,405,477,235.74 | 2,485,996,961.79 | 2,539,424,021.01 | 2,475,012,746.3 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 236,997,246.83 | 107,079,239.33 | 574,024,272.61 | 392,797,804.49 |
| 经营活动现金流出小计 | 228,882,875.68 | 125,067,771.78 | 467,556,172.17 | 318,724,322.49 |
| 经营活动产生的现金流量净额 | 8,114,371.15 | -17,988,532.45 | 106,468,100.44 | 74,073,482 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,000,551,687.37 | 909,703,750.15 | 5,481,408,505.61 | 4,344,794,810.89 |
| 投资活动现金流出小计 | 1,783,909,023.8 | 958,847,784 | 5,349,705,038.09 | 3,830,920,972.97 |
| 投资活动产生的现金流量净额 | 216,642,663.57 | -49,144,033.85 | 131,703,467.52 | 513,873,837.92 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 102,640,000 | 2,640,000 | 3,147,500 | 3,147,500 |
| 筹资活动现金流出小计 | 215,793,333.8 | - | 161,204,403.14 | 161,450,645.39 |
| 筹资活动产生的现金流量净额 | -113,153,333.8 | 2,640,000 | -158,056,903.14 | -158,303,145.39 |
| 汇率变动对现金及现金等价物的影响 | -32,503,908.83 | -17,537,266.19 | -12,677,811.46 | -9,947,456.31 |
| 现金及现金等价物净增加额 | 79,099,792.09 | -82,029,832.49 | 67,436,853.36 | 419,696,718.22 |
| 期末现金及现金等价物余额 | 1,250,296,076.61 | 1,089,166,452.03 | 1,171,196,284.52 | 1,523,456,149.38 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 79,099,792.09 | - | 67,436,853.36 | - |